Skip to main content
. 2002 Feb 1;70(3):781–786. doi: 10.1086/339077

Table 2.

Statistically Significant Differences in Eight SNPs among Patients with IgAN versus Control Subjects[Note]

Statistical Significance in Subjects with
Stratified Comparison SELE8 SELE13 SELL1 SELL4 SELL5 SELL6 SELL10 SELL11
χ2:
 Allele frequency 10.686095 11.572843 12.354986 12.242864 11.007155 22.701719 14.379202 12.292278
 Genotype frequency 11.704698 11.980555 19.773932 14.392873 13.899272 24.560263 18.609493 12.969646
 Major homozygotes/others 6.244945 7.624198 3.961227 5.494191 4.530285 10.306812 6.018957 7.538820
 Minor homozygotes/others 9.025162 8.026010 19.481165 12.982878 12.975893 22.013996 17.377607 9.470623
P:
 Allele frequency .001079 .000669 .000440 .000467 .000908 .000002 .000149 .000455
 Genotype frequency .002873 .002503 .000051 .000749 .000959 .000005 .000091 .001526
 Major homozygotes/others .012455 .005759 .046560 .019080 .033300 .001325 .014153 .006038
 Minor homozygotes/others .002663 .004611 .000010 .000314 .000316 .000003 .000031 .002088

Note.— The χ2 test was used to evaluate possible associations between different genotypes, allele frequencies, or patients.